Skip to Content

Taihe Group Inc TIHE

Morningstar Rating
$1.00 −4.00 (80.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TIHE is trading within a range we consider fairly valued.
Price
$3.29
Fair Value
$7.94
Uncertainty
Extreme
1-Star Price
$57.37
5-Star Price
$8.28
Economic Moat
Rzrkmg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TIHE is a good fit for your portfolio.

Trading Information

Previous Close Price
$5.00
Day Range
$1.001.00
52-Week Range
$1.005.00
Bid/Ask
$3.30 / $70.00
Market Cap
$71.85 Mil
Volume/Avg
2 / 2

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Total Number of Employees
Website

Comparables

Valuation

Metric
TIHE
QSI
GH
Price/Earnings (Normalized)
Price/Book Value
0.8939.90
Price/Sales
222.024.33
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TIHE
QSI
GH
Quick Ratio
22.236.11
Current Ratio
22.946.54
Interest Coverage
−198.43
Quick Ratio
TIHE
QSI
GH

Profitability

Metric
TIHE
QSI
GH
Return on Assets (Normalized)
−27.02%−17.37%
Return on Equity (Normalized)
−29.37%−213.40%
Return on Invested Capital (Normalized)
−30.81%−22.39%
Return on Assets
TIHE
QSI
GH
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncRdhhpfdnyGbmqb$220.6 Bil
DHR
Danaher CorpQctwmxvzxxCtdycz$184.8 Bil
A
Agilent Technologies IncGzwyympfpvNlsj$43.9 Bil
IQV
IQVIA Holdings IncPlmbmbhslRrrhjr$42.6 Bil
IDXX
IDEXX Laboratories IncLpllylpvLsjzk$42.1 Bil
MTD
Mettler-Toledo International IncZqwssddbfGmxbt$32.3 Bil
ICLR
Icon PLCTmjmcnmfSfgnlt$26.1 Bil
WAT
Waters CorpVptfbvkzqFcn$20.8 Bil
ILMN
Illumina IncVztllrbtKtrbcs$17.6 Bil
LH
Laboratory Corp of America HoldingsHpsqprwmdLkrnr$17.4 Bil

Sponsor Center